Wells Fargo & Company Exscientia PLC Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Exscientia PLC stock. As of the latest transaction made, Wells Fargo & Company holds 492,111 shares of EXAI stock, worth $2.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
492,111
Previous 562,101
12.45%
Holding current value
$2.6 Million
Previous $3.22 Million
21.96%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding EXAI
# of Institutions
90Shares Held
34.4MCall Options Held
22.8KPut Options Held
178K-
Softbank Group Corp Minato Ku Tokyo, M05.68MShares$30 Million0.15% of portfolio
-
Sb Global Advisers LTD London, X05.68MShares$30 Million3.51% of portfolio
-
Laurion Capital Management LP New York, NY5.14MShares$27.2 Million0.31% of portfolio
-
Baillie Gifford & CO3.85MShares$20.3 Million0.01% of portfolio
-
First Trust Advisors LP Wheaton, IL1.73MShares$9.14 Million0.01% of portfolio
About Exscientia plc
- Ticker EXAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,461,000
- Market Cap $647M
- Description
- Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...